These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23250105)

  • 1. Kinetic analysis of the metabotropic glutamate subtype 5 tracer [(18)F]FPEB in bolus and bolus-plus-constant-infusion studies in humans.
    Sullivan JM; Lim K; Labaree D; Lin SF; McCarthy TJ; Seibyl JP; Tamagnan G; Huang Y; Carson RE; Ding YS; Morris ED
    J Cereb Blood Flow Metab; 2013 Apr; 33(4):532-41. PubMed ID: 23250105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Test-retest reproducibility of the metabotropic glutamate receptor 5 ligand [¹⁸F]FPEB with bolus plus constant infusion in humans.
    Park E; Sullivan JM; Planeta B; Gallezot JD; Lim K; Lin SF; Ropchan J; McCarthy TJ; Ding YS; Morris ED; Williams WA; Huang Y; Carson RE
    Eur J Nucl Med Mol Imaging; 2015 Sep; 42(10):1530-41. PubMed ID: 26044120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of metabotropic glutamate subtype 5 receptors in the brain by an equilibrium method using 18F-SP203.
    Kimura Y; Siméon FG; Zoghbi SS; Zhang Y; Hatazawa J; Pike VW; Innis RB; Fujita M
    Neuroimage; 2012 Feb; 59(3):2124-30. PubMed ID: 22032949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic modeling and long-term test-retest reproducibility of the mGluR5 PET tracer 18F-FPEB in human brain.
    Leurquin-Sterk G; Postnov A; de Laat B; Casteels C; Celen S; Crunelle CL; Bormans G; Koole M; Van Laere K
    Synapse; 2016 Apr; 70(4):153-62. PubMed ID: 26799447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical Evaluation and Quantification of 18F-FPEB as a Radioligand for PET Imaging of the Metabotropic Glutamate Receptor 5.
    de Laat B; Leurquin-Sterk G; Celen S; Bormans G; Koole M; Van Laere K; Casteels C
    J Nucl Med; 2015 Dec; 56(12):1954-9. PubMed ID: 26405172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET imaging of mGluR5 in Alzheimer's disease.
    Mecca AP; McDonald JW; Michalak HR; Godek TA; Harris JE; Pugh EA; Kemp EC; Chen MK; Salardini A; Nabulsi NB; Lim K; Huang Y; Carson RE; Strittmatter SM; van Dyck CH
    Alzheimers Res Ther; 2020 Jan; 12(1):15. PubMed ID: 31954399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple and rapid quantification of serotonin transporter binding using [
    Gryglewski G; Rischka L; Philippe C; Hahn A; James GM; Klebermass E; Hienert M; Silberbauer L; Vanicek T; Kautzky A; Berroterán-Infante N; Nics L; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Kasper S; Lanzenberger R
    Neuroimage; 2017 Apr; 149():23-32. PubMed ID: 28119137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FPEB, a PET radiopharmaceutical for quantifying metabotropic glutamate 5 receptors: a first-in-human study of radiochemical safety, biokinetics, and radiation dosimetry.
    Wong DF; Waterhouse R; Kuwabara H; Kim J; Brašić JR; Chamroonrat W; Stabins M; Holt DP; Dannals RF; Hamill TG; Mozley PD
    J Nucl Med; 2013 Mar; 54(3):388-96. PubMed ID: 23404089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring the effects of ketamine on mGluR5 using [
    Holmes SE; Gallezot JD; Davis MT; DellaGioia N; Matuskey D; Nabulsi N; Krystal JH; Javitch JA; DeLorenzo C; Carson RE; Esterlis I
    J Cereb Blood Flow Metab; 2020 Nov; 40(11):2254-2264. PubMed ID: 31744389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and preliminary biological evaluation of 3-[(18)F]fluoro-5-(2-pyridinylethynyl)benzonitrile as a PET radiotracer for imaging metabotropic glutamate receptor subtype 5.
    Wang JQ; Tueckmantel W; Zhu A; Pellegrino D; Brownell AL
    Synapse; 2007 Dec; 61(12):951-61. PubMed ID: 17787003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two PET radioligands, [
    Lohith TG; Tsujikawa T; Siméon FG; Veronese M; Zoghbi SS; Lyoo CH; Kimura Y; Morse CL; Pike VW; Fujita M; Innis RB
    J Cereb Blood Flow Metab; 2017 Jul; 37(7):2458-2470. PubMed ID: 27629098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain.
    Van Laere K; Ahmad RU; Hudyana H; Dubois K; Schmidt ME; Celen S; Bormans G; Koole M
    J Nucl Med; 2013 Aug; 54(8):1285-93. PubMed ID: 23843566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of age on brain metabotropic glutamate receptor subtype 5 measured with [
    Mecca AP; Rogers K; Jacobs Z; McDonald JW; Michalak HR; DellaGioia N; Zhao W; Hillmer AT; Nabulsi N; Lim K; Ropchan J; Huang Y; Matuskey D; Esterlis I; Carson RE; van Dyck CH
    Neuroimage; 2021 Sep; 238():118217. PubMed ID: 34052464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of Metabotropic Glutamate Receptor 5 Availability With Both [
    Glorie D; Verhaeghe J; Miranda A; De Lombaerde S; Stroobants S; Staelens S
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2022 Jun; 7(6):607-615. PubMed ID: 34856382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo variation in same-day estimates of metabotropic glutamate receptor subtype 5 binding using [
    DeLorenzo C; Gallezot JD; Gardus J; Yang J; Planeta B; Nabulsi N; Ogden RT; Labaree DC; Huang YH; Mann JJ; Gasparini F; Lin X; Javitch JA; Parsey RV; Carson RE; Esterlis I
    J Cereb Blood Flow Metab; 2017 Aug; 37(8):2716-2727. PubMed ID: 27742888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A first-in-man PET study of [
    Warnock G; Sommerauer M; Mu L; Pla Gonzalez G; Geistlich S; Treyer V; Schibli R; Buck A; Krämer SD; Ametamey SM
    Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):1041-1051. PubMed ID: 29177707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic Modeling and Test-Retest Reproducibility of
    Naganawa M; Li S; Nabulsi N; Lin SF; Labaree D; Ropchan J; Gao H; Mei M; Henry S; Matuskey D; Carson RE; Huang Y
    J Nucl Med; 2020 Nov; 61(11):1636-1642. PubMed ID: 32169917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging of cerebral α4β2* nicotinic acetylcholine receptors with (-)-[(18)F]Flubatine PET: Implementation of bolus plus constant infusion and sensitivity to acetylcholine in human brain.
    Hillmer AT; Esterlis I; Gallezot JD; Bois F; Zheng MQ; Nabulsi N; Lin SF; Papke RL; Huang Y; Sabri O; Carson RE; Cosgrove KP
    Neuroimage; 2016 Nov; 141():71-80. PubMed ID: 27426839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of [
    Krzyczmonik A; Grafinger KE; Keller T; Pfeifer L; Forsback S; Haaparanta-Solin M; Gouverneur V; López-Picón F; Solin O
    Nucl Med Biol; 2023; 116-117():108309. PubMed ID: 36521341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of influence of the glutamatergic concentration of [
    Dupont AC; Serrière S; Barantin L; Vercouillie J; Tauber C; Gissot V; Bodard S; Chicheri G; Chalon S; Bonnet-Brilhault PF; Santiago-Ribeiro PM; Arlicot N
    Transl Psychiatry; 2021 Jan; 11(1):66. PubMed ID: 33473111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.